MAE-WEST SCORE Career Enhance Core
MAE-WEST SCORE 职业提升核心
基本信息
- 批准号:10450757
- 负责人:
- 金额:$ 14.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateAgeAgingAlzheimer&aposs disease related dementiaAnalytical ChemistryAreaBasic ScienceBioinformaticsBiologicalBiological AgingBiometryBlood VesselsBrainCaliforniaCardiologyCenters of Research ExcellenceChemistryChronicChronic DiseaseChronic Kidney FailureChronologyClinicalClinical ResearchClinical TrialsCollaborationsCommunitiesData AnalyticsDementiaDevelopmentDiseaseDisease OutcomeEFRACEducationEicosanoidsElderlyEnvironmentEpidemiologistEpidemiologyEvaluationFacultyFailureFemaleFoundationsFunctional disorderFundingGeriatricsGerontologyGoalsGonadal Steroid HormonesGrantHeartHeart failureHumanInflammationInflammatoryInfrastructureLeadLife Cycle StagesLongevityMeasurementMediator of activation proteinMedicalMedical centerMentorsMethodologyMicrovascular DysfunctionMissionMolecular ProfilingMorbidity - disease rateNatureNephrologyNeurologyOphthalmologyOrganPhysiologyPilot ProjectsProductivityPublic HealthRenal functionRequest for ApplicationsResearchResearch ActivityResearch MethodologyResearch PersonnelResearch TrainingResourcesScientific Advances and AccomplishmentsScientistSeedsSex DifferencesSpecialized CenterStructureTechniquesTestingTrainingTraining ActivityTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesVariantWomanWomen&aposs HealthWorkage effectage relatedcareercareer developmentclinical developmenteffective interventionexperiencefrailtyhands on researchhealth differenceheart functionimplementation interventionimprovedinfrastructure developmentinnovationinterdisciplinary approachmenmicrovascular agingmultidisciplinaryneurocognitive testnext generationpopulation healthpreservationprogramsresponsesexsex disparitysexual dimorphismstressortranslational scientist
项目摘要
Project Abstract – MAE-WEST SCORE CEC
Over the course of life, chronic stressors contribute to multi-organ aging and dysfunction and, ultimately, the
development of clinical disease. Sex remains a critical determinant of the nature and pace of aging and ultimately
longevity. With advancing chronologic age in humans, differences in biological aging between women and men
become even more pronounced, culminating in the female predominance for a number of important morbid
disease conditions, including notably Alzheimer’s disease and related dementias (ADRD), heart failure with
preserved ejection fraction (HFpEF), progressive chronic kidney disease (CKD), and in turn systemic frailty.
Mechanisms underlying the female predominance for these major morbidities remains unknown and are not
explained by variations in sex hormones or survival bias. Our preliminary work supports a central hypothesis that
sexual dimorphism in inflammatory eicosanoid mediators contribute to sex differences in microvascular
dysfunction and, in turn, to sex differences in age-related multi-organ disease, including for ADRD, HFpEF and
CKD. Elucidating a common pathophysiologic basis for the female predominance of ADRD, HFpEF, and CKD
holds the key to effective interventions for reducing the excess burden of age-related disease in women.
Motivated our findings and the critical need to understand the determinants and drivers of sex differences in
major age-related disease outcomes, we propose to establish the Microvascular Aging and Eicosanoids –
Women’s Evaluation of Systemic aging Tenacity (MAE-WEST) (“You are never too old to become younger!”)
Specialized Center of Research Excellence (SCORE) on Sex Differences, in response to NIH RFA-OD-19-013.
Our goal is to form a robust and sustainable structure of academic activities centered on systematically
interrogating sex differences in the relationship among eicosanoids, microvascular dysfunction, and age-related
end-organ disease, with an initial focus on the microvascular aging effects on brain, heart, and kidney function.
This goal will be achieved by an outstanding collaborative team of clinician-scientists (with expertise in geriatrics,
cardiology, and nephrology), epidemiologists, basic and translational scientists, analytical chemists,
biostatisticians, and bioinformaticians. Leveraging our collective experience, resources, and infrastructure, we
will advance the scientific enterprise through 3 foundational projects aligned and complementary yet
independent. To promote and enhance the development of the next generation of early career investigators who
are committed to studying sex differences in biomedicine, our MAE-WEST SCORE program will provide a robust,
multi-disciplinary Career Enhancement Core. Methodological expertise areas include: epidemiology, clinical
trials, basic science, analytical chemistry, biostatistics and bioinformatics, neurocognitive testing, integrated
physiology, and global functional assessments. Content and clinical areas of expertise that will maximize the
potential for translation of research findings to practice include: geriatrics and gerontology, neurology and neuro-
ophthalmology, cardiology, nephrology, and women’s health.
项目摘要 - MAE-West分数CEC
在生活过程中,长期压力源导致多器官衰老和功能障碍,最终导致
临床疾病的发展。性仍然是对衰老的性质和节奏的关键决定者
长寿。随着人类年龄的增长,男女之间的生物衰老差异
变得更加明显,最终在女性占主导地位的许多重要病态
疾病状况,包括尤其是阿尔茨海默氏病和相关痴呆症(ADRD),心力衰竭
保留的射血分数(HFPEF),进行性慢性肾脏疾病(CKD)和全身脆弱。
女性占主导地位的机制尚不清楚,不是
用性激素或生存偏见的变化解释。我们的初步工作支持一个中心假设,即
炎症性类花生酸介质中的性二态性有助于微血管的性别差异
功能障碍,反过来,与年龄相关的多器官疾病的性别差异,包括ADRD,HFPEF和
CKD。阐明ADRD,HFPEF和CKD女性占主导地位的常见病理生理基础
是减少女性与年龄相关疾病过多的有效干预措施的关键。
激发了我们的发现以及了解性别差异的决定者和驱动力的批判性需求
与年龄相关的主要疾病结局,我们建议建立微血管衰老和类花生素 -
妇女对系统性老化的庄严性评估(Mae-West)(“您永远不会太老,无法年轻!”)
针对NIH RFA-OD-19-013的专业研究中心卓越研究中心(得分)。
我们的目标是形成以系统为中心的学术活动的强大而可持续的结构
询问类花生酸,微血管功能障碍和与年龄有关的性别差异
最初的器官疾病,最初侧重于微血管衰老对大脑,心脏和肾功能的影响。
这个目标将由临床科学家的杰出合作团队实现(具有老年医学专业知识,
心脏病学和肾脏病),流行病学家,基础和翻译科学家,分析化学家,
生物统计学家和生物信息学家。利用我们的集体经验,资源和基础设施,我们
将通过3个结盟和补充的基础项目推进科学企业
独立的。促进和增强下一代职业调查人员的发展
致力于研究生物医学的性别差异,我们的MAE-West分数计划将提供强大的,
多学科职业增强核心。方法论专业知识领域包括:流行病学,临床
试验,基础科学,分析化学,生物统计学和生物信息学,神经认知测试,综合
生理学和全球功能评估。内容和专业知识的临床领域将最大化
进行研究结果翻译的潜力包括:老年医学和老年学,神经病学和神经学
眼科,心脏病学,肾脏病和妇女健康。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Cathleen Noel Bairey Merz其他文献
Cathleen Noel Bairey Merz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Cathleen Noel Bairey Merz', 18)}}的其他基金
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
- 批准号:
10198755 - 财政年份:2020
- 资助金额:
$ 14.25万 - 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
- 批准号:
10450755 - 财政年份:2020
- 资助金额:
$ 14.25万 - 项目类别:
MAE-WEST SCORE Leadership Administrative Core
MAE-WEST SCORE 领导力行政核心
- 批准号:
10450756 - 财政年份:2020
- 资助金额:
$ 14.25万 - 项目类别:
MAE-WEST SCORE Leadership Administrative Core
MAE-WEST SCORE 领导力行政核心
- 批准号:
10198756 - 财政年份:2020
- 资助金额:
$ 14.25万 - 项目类别:
The Microvascular Aging and Eicosanoids - Women's Evaluation of Systemic Aging Tenacity (MAE-WEST) ("You are never too old to become younger!") Specialized Center for Research Excellence (SCORE)
微血管老化和类二十烷酸 - 女性全身老化韧性评估 (MAE-WEST)(“你永远不会太老,变得更年轻!”)卓越研究专业中心 (SCORE)
- 批准号:
10817498 - 财政年份:2020
- 资助金额:
$ 14.25万 - 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
- 批准号:
9922714 - 财政年份:2019
- 资助金额:
$ 14.25万 - 项目类别:
Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF)
女性缺血综合征评估 (WISE) - 冠状动脉微血管功能障碍导致射血分数保留 (HFpEF) 的先兆心力衰竭的机制
- 批准号:
10576287 - 财政年份:2019
- 资助金额:
$ 14.25万 - 项目类别:
相似海外基金
Differences in Hospital Nursing Resources among Black-Serving Hospitals as a Driver of Patient Outcomes Disparities
黑人服务医院之间医院护理资源的差异是患者结果差异的驱动因素
- 批准号:
10633905 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Learning and Living with Wildfire Smoke: Creating Clean Air Environments in Schools through Youth Participatory Action Research
与野火烟雾一起学习和生活:通过青年参与行动研究在学校创造清洁的空气环境
- 批准号:
10662674 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Peer suppoRt for adolescents and Emerging adults with Sickle cell pain: promoting ENgagement in Cognitive behavioral thErapy
对患有镰状细胞痛的青少年和新兴成年人的同伴支持:促进认知行为治疗的参与
- 批准号:
10745058 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Developing a Scalable FASD-Informed Person-Centered Planning Intervention
制定可扩展的 FASD 知情的以人为中心的规划干预措施
- 批准号:
10644186 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别:
Inter-CFAR Women and HIV Biennial Symposium
Inter-CFAR 妇女与艾滋病毒双年研讨会
- 批准号:
10762305 - 财政年份:2023
- 资助金额:
$ 14.25万 - 项目类别: